Skip to Main Content
Services Talent Knowledge
Site Search


Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

February 8, 2022

Cannabis Control Board Issues Cease and Desist Letters to Establishments Engaged in Unlicensed Sale of Cannabis Products in New York State

The Cannabis Control Board (CCB) has addressed the gifting of cannabis in connection with a commercial transaction several times in CCB meetings as well as various community events. However, the problem has persisted in a very public manner, with many towns and law enforcement officials confused on the legality of the transactions and how best to enforce the law in these circumstances.

The CCB has now taken its first real step in reining in the unlicensed sale of cannabis in New York State. The Office of Cannabis Management (OCM) has sent a cease and desist letter to more than two dozen businesses engaged in commercial transactions that purport to gift cannabis. The OCM letter stated, “Unlicensed sales . . . are not lab-tested and potentially threaten public health and safety.” Clarifying further, the OCM stated that “Illegal sales include the sale of cannabis products in-person at a retail location, online, via delivery, or at an event; and include so-called ‘gifting’ where consumers purchase non-cannabis items or services, such as a membership in a club, and are then provided cannabis as part of the sale.”

There have been countless stories published about businesses believing, sometimes under the advice of counsel, they have found a loophole in the law that allows for unlicensed, but legal, sales of adult-use cannabis. The OCM Enforcement Unit—relatively unknown until now but one that will likely feature prominently in the future—has brought absolute certainty to the industry by clearly stating that these transactions are illegal.

The OCM further warned the businesses that received the letter that “failure to cease this activity puts your ability to obtain a license in the legal cannabis market at substantial risk. The unlicensed sale of cannabis is illegal and subjects you to substantial fines and possible criminal penalties.”

Lastly, the letter indicates that landlords that host these types of illegal cannabis activities are jeopardizing their ability to lease to adult-use dispensaries and on-site consumption lounges in the future.

People with questions or concerns about illicit cannabis transactions are encouraged to reach out to the OCM Enforcement Unit at

This is an important step for New York State’s nascent cannabis industry. The protection of public health and establishment of a fully regulated and legal cannabis market can be jeopardized by the illicit sale of cannabis purporting to be legal. Consumers can be misled into believing the illicit cannabis has been tested and is safe to consume, which can lead to an erosion of trust in the adult-use market.

Barclay Damon’s Cannabis Team will continue to closely monitor developments pertaining to the MRTA’s rules and regulations. If you have questions about the MRTA, please contact one of Barclay Damon’s cannabis attorneys. 

If you have questions regarding the content of this alert, please contact Jason Klimek, Cannabis Team co-leader, at, or another member of the firm’s Cannabis Team.


Click here to sign up for alerts, blog posts, and firm news.

Featured Media


Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Gladys Vasquez, Monique Reid, Raymond Forrest, Pedro Martinez, Linda Slade, and Felipe Fernandez—Targeting Businesses in Recent Flurry of Lawsuits


Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Compres, Sanchez, Fontanez, Pajaro, Garcia, and Jaquez—Targeting Businesses in Recent Flurry of Lawsuits


Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Competello, Fernandez, Liz, Riley, and Trippett—Targeting Businesses in Recent Flurry of Lawsuits


CDPAP Providers Get First Look at the Future of CDPAP Without FIs


New York State Fiscal Year 2025 Budget: Implications for Employers Unpacked


Lab Providers Under Increased Scrutiny From Civil and Criminal Agencies for OTC COVID-19 Test Claims

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out